Telomir Pharmaceuticals, Inc. Repayments of Related Party Debt
Telomir Pharmaceuticals, Inc. (TELO) reported Repayments of Related Party Debt of $317.71 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2026-08-13
- Telomir Pharmaceuticals, Inc. repayments of related party debt for the quarter ending 2024-09-30 was -$85.53K.
- Telomir Pharmaceuticals, Inc. repayments of related party debt for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Telomir Pharmaceuticals, Inc. repayments of related party debt for the quarter ending 2024-03-31 was $519.48K, a 96.87% increase year-over-year.
- Telomir Pharmaceuticals, Inc. repayments of related party debt for the quarter ending 2023-06-30 was $317.39K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month |
|---|---|---|---|
| 2026-06-30 | $317.71K 10-Q · filed 2026-08-13 | ||
| 2024-09-30 | -$85.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$85.53K derived: sum of 2 quarters · filed 2025-11-10 | $433.95K 10-Q · filed 2025-11-10 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $519.48K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $519.48K 10-Q · filed 2025-05-14 | ||
| 2023-06-30 | $317.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $581.26K 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $263.87K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |